Cargando…
Spontaneous colitis in IL‐10‐deficient mice was ameliorated via inhibiting glutaminase1
Immunity imbalance and barrier damage in the intestinal mucosa are the main pathogenic factors of Crohn's disease (CD). Bis‐2‐(5‐phenylacetamido‐1,2,4‐thiadiazol‐2‐yl) ethyl sulfide (BPTES) is a glutaminase 1 (Gls1) inhibitor with the dual functions of increasing glutamine levels and immune reg...
Autores principales: | Li, Jing, Zuo, Lugen, Tian, Yun, He, Yifan, Zhang, Zhichao, Guo, Pu, Ge, Yuanyuan, Hu, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653008/ https://www.ncbi.nlm.nih.gov/pubmed/31211512 http://dx.doi.org/10.1111/jcmm.14471 |
Ejemplares similares
-
Bryostatin‐1 ameliorated experimental colitis in Il‐10
(−/−) Mice by protecting the intestinal barrier and limiting immune dysfunction
por: Zuo, Lugen, et al.
Publicado: (2019) -
Epac‐2 ameliorates spontaneous colitis in Il‐10
(−/−) mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling
por: Song, Xue, et al.
Publicado: (2021) -
Targeting hepatic glutaminase activity to ameliorate hyperglycemia
por: Miller, Russell A., et al.
Publicado: (2018) -
Correction to Epac‐2 ameliorates spontaneous colitis in Il‐10
(−/−) mice by protecting the intestinal barrier and suppressing NF‐κB/MAPK signalling
Publicado: (2023) -
Pygopus2 ameliorates mesenteric adipocyte poor differentiation to alleviate Crohn's disease ‐like colitis via the Axin2/GSK3β pathway
por: Li, Jing, et al.
Publicado: (2022)